Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme

@article{Schiff2008BevacizumabIC,
  title={Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme},
  author={D. Schiff and B. Purow},
  journal={Nature Clinical Practice Oncology},
  year={2008},
  volume={5},
  pages={186-187}
}
  • D. Schiff, B. Purow
  • Published 2008
  • Medicine
  • Nature Clinical Practice Oncology
  • Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme 
    12 Citations
    Therapeutic strategies for inhibiting invasion in glioblastoma
    • 66

    References

    SHOWING 1-6 OF 6 REFERENCES
    Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.
    • 1,268
    • PDF
    Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
    • 1,005
    • PDF
    Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study.
    • 387
    • PDF